Empowering Scientific Breakthroughs: How Scientists Can Use AI and ML for Drug Discovery, Upcoming Webinar Hosted by Xtalks
Thursday, October 17, 2024
In this free webinar, gain insights into how artificial intelligence (AI) and machine learning (ML) are being practically applied in drug discovery. Attendees will learn about tools that could potentially streamline research processes. The featured speakers will discuss the future direction of AI in life sciences and its impact. The speakers will also share insights on how to enhance scientific workflows with augmented intelligence.
TORONTO, Oct. 9, 2024 /PRNewswire-PRWeb/ -- In the rapidly evolving field of drug discovery, artificial intelligence (AI) and machine learning (ML) have become well-known multipliers in accelerating research and enhancing the development of therapeutic compounds.
The goal of augmented intelligence is to create solutions that support decision-making processes and accelerate routine tasks, allowing researchers to dedicate more time to higher-level analysis and creative problem-solving.This talk will explore Revvity Signals' strategic journey and share details of existing AI/ML integrations into current Revvity Signals' software solutions. The team will also discuss the future picture and direction of travel for AI/ML and their software solutions. The speakers will share their future direction and pipeline and explore how these solutions will continue to empower scientists to drive significant breakthroughs in drug discovery.
They will share their insights into the opportunities afforded by AI/ML. Specifically, they will provide examples of how these tools are currently assisting researchers in their daily work in two ways: 1) to help scientists document or efficiently use the software and 2) to help scientists accelerate their science.
They will also discuss augmented intelligence, where AI and ML tools complement and enhance human expertise rather than replace it. The goal of augmented intelligence is to create solutions that support decision-making processes and accelerate routine tasks, allowing researchers to dedicate more time to higher-level analysis and creative problem-solving.
Register for this webinar today to discover how cutting-edge AI and ML technologies are being leveraged for drug discovery and development.
Join experts from Revvity Signals, Zev Wisotsky, Director of Drug Discovery Informatics; and David Gosalvez, PhD, Executive Director, Strategy & Informatics Portfolio, for the live webinar on Tuesday, October 29, 2024, at 11am EDT (4pm CET/EU-Central).
For more information, or to register for this event, visit Empowering Scientific Breakthroughs: How Scientists Can Use AI and ML for Drug Discovery.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com, https://xtalks.com
View original content to download multimedia:https://www.prweb.com/releases/empowering-scientific-breakthroughs-how-scientists-can-use-ai-and-ml-for-drug-discovery-upcoming-webinar-hosted-by-xtalks-302271238.html
SOURCE Xtalks
|
|
|
|
|
 |
VIAVI Highlights Test Solutions for AI Infrastructure Development, Manufacturing and Deployment at OFC 2025 | Mar 28, 2025
|
|
Orium Launches Composable Accelerator for Shopify | Mar 28, 2025
|
|
Oracle Helps Customers Boost Employee Engagement with Strategic Communications and Internal Events | Mar 28, 2025
|
|
ThreatQuotient positioned as a Leader in the SPARK Matrix(TM): Digital Threat Intelligence Management, 2025 by QKS Group | Mar 28, 2025
|
|
Madame Rachida Dati, French Minister of Culture, has granted official recognition to thierry Ehrmann's Abode of Chaos as a 'total work of art', the global headquarters of Artprice by Artmarket. | Mar 28, 2025
|
|
Datacenter Dynamics Makes History with LoneStar - Becoming the World's First Magazine to Reach the Moon | Mar 28, 2025
|
|
Oracle Named a Leader in Configure, Price, Quote by Independent Research Firm | Mar 28, 2025
|
|
Nosto reports 323% growth of Personalized Search after 2024 Gartner MQ inclusion | Mar 28, 2025
|
|
Western Union forms strategic partnership with HCLTech to transition to an AI led platform operating model | Mar 28, 2025
|
|
Wealthbox Expands to Canada with In-Country Data Hosting | Mar 28, 2025
|
|
|
